logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Rajiv Gandhi Cancer Institute & Research Centre

Verified
+91-11-47022222
info@rgcirc.org
Source: Site record.
https://www.rgcirc.org

Basic Information

Site Overview

Source: Human-provided.

Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is one of Asia’s foremost dedicated cancer treatment and research centres, established in 1996 as a project of the Indraprastha Cancer Society & Research Centre. It operates major campuses in Rohini (North Delhi) and Niti Bagh (South Delhi), offering comprehensive oncology care backed by advanced technology and multidisciplinary expertise. RGCIRC provides a full spectrum of cancer services including medical oncology, surgical oncology, radiation oncology, paediatric oncology, bone marrow transplant, nuclear medicine, pathology, and supportive/palliative care. The institute combines evidence-based clinical practice with cutting-edge treatments and robust diagnostic facilities such as PET-CT and modern laboratories, serving patients from across India and neighbouring countries. With round-the-clock emergency services, specialised tumour boards, telemedicine and a focus on research and education, RGCIRC is recognised for quality…

Source: Trial-derived.
57Total Trials
Source: Trial-derived.
14Recruiting Trials
Source: Trial-derived.
30Active Trials
Source: Trial-derived.
26Completed Trials
Source: Trial-derived.
62Unique Conditions
Source: Trial-derived.
24Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (5)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (4)Source: Trial-derived. Breast Neoplasms (2)Source: Trial-derived. Colorectal Neoplasms (2)Source: Trial-derived. Paroxysmal Nocturnal Hemoglobinuria (2)Source: Trial-derived. Prostate Cancer (2)Source: Trial-derived. Acute Myeloid Leukemia (1)Source: Trial-derived. Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia (1)

Sponsors

Source: Trial-derived. Pfizer (15)Source: Trial-derived. Rajiv Gandhi Cancer Institute & Research Center, India (11)Source: Trial-derived. Hoffmann-La Roche (8)Source: Trial-derived. Janssen Research & Development, LLC (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. Regeneron Pharmaceuticals (2)Source: Trial-derived. Takeda (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Amenities

Amenities Available

Source: Google. Restroom
Source: Google. Gender-neutral restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Bladder mapping biopsies
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Intravesical drug instillation
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. RET fusion testing
Source: AI-inferred. Tumour FGFR molecular alteration testing
Source: AI-inferred. Urine cytology